Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: Optimal Intensity of Anticoagulation.Published in:CNS Drugs, 2001, v. 15, n. 8, p. 623, doi. 10.2165/00023210-200115080-00005By:Yasaka, M.;Yamaguchi, T.Publication type:Article
When should triptans be taken during a migraine attack?Published in:2001By:Schoenen, J.Publication type:journal article
Do statins afford neuroprotection in patients with cerebral ischaemia and stroke?Published in:2001By:Vaughan, C.J.;delanty, N.;Basson, C.T.Publication type:journal article
CNS involvement in primary Sjögren's syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach.Published in:2001By:Govoni, M.;Padovan, M.;Rizzo, N.;Trotta, F.Publication type:journal article
Harnessing the clinical potential of antiepileptic drug therapy: dosage optimisation.Published in:2001By:Perucca, E.;Dulac, O.;Shorvon, S.;Tomson, T.Publication type:journal article
Adverse effects of antiepileptic drugs on bone structure: epidemiology, mechanisms and therapeutic implications.Published in:2001By:Pack, A.M.;Morrell, M.J.Publication type:journal article
Venlafaxine Extended-Release: A Review of its Use in the Management of Major Depression.Published in:CNS Drugs, 2001, v. 15, n. 8, p. 643, doi. 10.2165/00023210-200115080-00007By:Wellington, K.;Perry, C.M.Publication type:Article